Medication Safety in Pregnancy?

Help future moms and babies by enrolling into our Actemra® & pregnancy study.

MotherToBaby is currently enrolling pregnant women in an observational study to explore how rheumatoid arthritis (RA) and its treatment affect pregnancy. All studies are conducted through phone interviews–-no changes to your normal routine or travel required. If you’ve taken Actemra® (tocilizumab) and are pregnant, you may qualify for this important study.‎

“There is a huge need to generate more data for all of the drugs that pregnant women need to take.”

— Christina Chambers, PhD MPH, MotherToBaby Pregnancy Studies

MotherToBaby is listed as a resource for information about medications in pregnancy by the US Food and Drug Administration (FDA) and the Centers for Disease Control and Prevention (CDC).

Volunteer for our pregnancy study to improve the health of moms & babies.

Your information is confidential.

Questions? Call 866.626.6847 | Text 855.999.3525 | Email or Chat at MotherToBaby.org.

Disclaimer: MotherToBaby Fact Sheets are meant for general information purposes and should not replace the advice of your health care provider. MotherToBaby is a service of the non-profit Organization of Teratology Information Specialists (OTIS). OTIS/MotherToBaby encourages inclusive and person-centered language. While our name still contains a reference to mothers, we are updating our resources with more inclusive terms. Use of the term mother or maternal refers to a person who is pregnant. Use of the term father or paternal refers to a person who contributes sperm. Copyright by OTIS, April 30, 2019.